序号 |
标题 |
次数 |
作者 |
发布时间 |
77536 |
Mal-PEG2-Val-Ala-PAB-PNP,马来酰亚胺-二聚乙二醇-VAL-ALA-PAB-PNP 酯 |
112 |
kx |
2024-12-18 |
77537 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)螯合物偶联配体[SHALs]) |
102 |
h |
2024-12-18 |
77538 |
DOTA(Gd))-b-PCL DOTA(Gd)螯合物修饰聚己内酯聚合物胶束 |
95 |
h |
2024-12-18 |
77539 |
土贝母苷甲脂质体,Tub,I-LPs,载药脂质体定制服务 |
87 |
axc |
2024-12-18 |
77540 |
半乳糖-RGD2 Galacto-RGD2 |
116 |
h |
2024-12-18 |
77541 |
DOTA-dPEG2-R954 DOTA偶联B1R拮抗剂R954 |
90 |
h |
2024-12-18 |
77542 |
竹节参皂苷Ⅳa脑靶向脂质体,脂质体纳米载体定制服务 |
132 |
axc |
2024-12-18 |
77543 |
cas:253863-34-2,Aloc-D-Ala-Phe-Lys(Aloc)-PAB-PNP,ADC定制 |
89 |
wyh |
2024-12-18 |
77544 |
CAS: 1343407-91-9 Alloc-Val-Ala-PAB(或Val-Ala-PAB-OH) |
98 |
WYQ |
2024-12-18 |
77545 |
DOTA-PEG-NH2 DOTA-聚乙二醇-氨基 |
107 |
h |
2024-12-18 |
77546 |
R-8PEG-4PCL的介绍 |
94 |
zyl |
2024-12-18 |
77547 |
N3-tri-EG-OPFP,ADC定制 |
81 |
wyh |
2024-12-18 |
77548 |
cas:1949793-41-2, Mal-amido-PEG4-Val-Cit-PAB-OH,马来酰亚胺-四聚乙二醇-VAL-CIT-PAB |
87 |
kx |
2024-12-18 |
77549 |
甘露糖修饰脂质体包装ASFV,CP204L基因,多功能载药脂质体定制服务 |
99 |
axc |
2024-12-18 |
77550 |
DOTA-βA-NH2 |
97 |
h |
2024-12-18 |
77551 |
Py-ds-dmBut-OPFP,2101206-44-2,ADC定制 |
91 |
wyh |
2024-12-18 |
77552 |
ALD-di-EG-OPFP,ADC定制 |
80 |
wyh |
2024-12-18 |
77553 |
cas:2055047-18-0,Azido-PEG3-Val-Cit-PAB-PNP,叠氮-三聚乙二醇-VAL-CIT-PAB-PNP 酯 |
71 |
kx |
2024-12-18 |
77554 |
柠檬草精油脂质体,LONL,载药脂质体定制服务 |
120 |
axc |
2024-12-18 |
77555 |
cas:159857-79-1,Val-cit-PAB-OH,ADC定制 |
94 |
wyh |
2024-12-18 |
77556 |
双载IR780与HCQ的温敏脂质体(IR780/HCQ-Lip) |
125 |
axc |
2024-12-18 |
77557 |
endo BCN-PEG3-Val-Cit,(1R,8S,9S)-双环[6.1.0]壬-三聚乙二醇-VAL-CIT |
79 |
kx |
2024-12-18 |
77558 |
DOTA-(PEG28)2-A20FMDV2 双末端聚乙二醇化的A20FMDV2偶联DOTA大环配体 |
90 |
h |
2024-12-18 |
77559 |
PEG2K-Hyd-PEI聚合物包裹共载SS31肽和胰岛素的脂质体纳米粒,PHP-DPS@INS,NPs |
106 |
axc |
2024-12-18 |
77560 |
cas:2226472-28-0 ,DBCO-PEG4-Val-Cit-PAB-PNP,二苯并环辛炔-四聚乙二醇-VAL-CIT-PAB-PNP 酯 |
84 |
kx |
2024-12-18 |
77561 |
FA-PEG-DOTA 叶酸-聚乙二醇-DOTA |
74 |
h |
2024-12-18 |
77562 |
OA-PEG5烷基链定制 |
113 |
zyl |
2024-12-18 |
77563 |
共载SS31肽和胰岛素的脂质体纳米粒,DPS@INS,NPs,脂质体纳米载体定制服务 |
111 |
axc |
2024-12-18 |
77564 |
DOTA-PEG27-Cys-VS |
81 |
h |
2024-12-18 |
77565 |
cas:1613321-01-9 ,6-Azidohexanoyl-Val-Cit-PAB,6-叠氮己酰-VAL-CIT-PAB |
79 |
kx |
2024-12-18 |
77566 |
MPA-PEG4-GB-6的功能与应用 |
127 |
zyl |
2024-12-18 |
77567 |
DOTA-PEG-GA DOTA-聚乙二醇-甘草次酸 |
76 |
h |
2024-12-18 |
77568 |
负载吡非尼酮的肺靶向纳米脂质体,GALA-PFD-Lip,多功能载药脂质体定制服务 |
141 |
axc |
2024-12-18 |
77569 |
PAMAM-PG-g-s-s-DOTA(Gd)+FA 纳米球状MRI造影剂 |
106 |
h |
2024-12-18 |
77570 |
DBCO-Val-Cit-PAB-MMAE,二苯并环辛炔-VAL-CIT-PAB-MMAE |
69 |
kx |
2024-12-18 |
77571 |
脂质体包裹噬菌体ABSZ6(LIP-ABSZ6),载药脂质体定制服务 |
288 |
axc |
2024-12-18 |
77572 |
DOTA-3G3-dimer DOTA-3G3-二聚体 |
74 |
h |
2024-12-18 |
77573 |
CAS: 1884578-27-1 Alloc-Val-Ala-PAB-PNP |
85 |
WYQ |
2024-12-18 |
77574 |
cas:646502-53-6 ,MC-Val-Cit-PAB-MMAE,VCMMAE 单甲基奥瑞他汀E |
95 |
kx |
2024-12-18 |
77575 |
布地奈德脂质体,Budesonide,liposomes,BUD-LNPs,靶向脂质体定制服务 |
100 |
axc |
2024-12-18 |
77576 |
DOTA-Lys-PEG4-[D-Phe6,Sta13]-BN(6-14)NH2(HZ219)DOTA缀合的GRPr拮抗剂 |
90 |
h |
2024-12-18 |
77577 |
[131I]SIB-PEG4-CHC 聚乙二醇化秋水仙素衍生物-定制 |
153 |
zyl |
2024-12-18 |
77578 |
PEG-G5.NH2-FITC-DOTA(Gd)-Monalizumab/IPH4301纳米探针 |
79 |
h |
2024-12-18 |
77579 |
虾青素脂质体,提供荧光脂质体定制服务 |
113 |
axc |
2024-12-18 |
77580 |
PEG2-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2;peg2-RM26-科研定制 |
163 |
zyl |
2024-12-18 |